The ascendancy of Viagra and its impact on the drug landscape presents a complex question for shareholders. While the initial sales figures were astounding, the patent has lapsed, leading to a wave of off-brand https://zoepkzd863165.blogacep.com/47016500/the-blue-pill-and-big-pharma-a-dangerous-opportunity